Hyaluronic%25252525252525252525252525252525252520acid

# Hyaluronic Acid ## Overview Hyaluronic acid (hyaluronan) is a naturally occurring glycosaminoglycan found in connective, epithelial, and neural tissues. Therapeutically, it is used as a viscoelastic agent in ophthalmology, a joint lubricant (viscosupplementation) for osteoarthritis, and a dermal filler or topical skin hydrator. ## Primary Indications * **Ophthalmology:** Surgical aid in cataract extraction, intraocular lens (IOL) implantation, and corneal transplant. * **Orthopedics:** Symptomatic treatment of knee osteoarthritis (OA) after failure of conservative therapy. * **Dermatology:** Dermal filler for facial wrinkles and aesthetic volume enhancement; topical moisturizer. ## Adult Dosing * **Intra-articular (Knee OA):** Dosing depends on the specific product formulation (e.g., Synvisc, Hyalgan, Euflexxa). Typical regimens range from a single 6 mL injection to a weekly series of 3–5 injections (2 mL each per session). Do not exceed manufacturer-specific recommendations for repeat cycles (typically every 6 months). * **Ophthalmic:** Quantity used is determined by the surgical procedure requirements (depth of the anterior chamber); administered by the surgeon. * **Dermal:** Variable based on product density and cosmetic site; administered via subdermal/intradermal injection by trained professionals. ## Pediatric Dosing * **No established pediatric efficacy or safety profile** for intra-articular or dermal indications. Use is not recommended in pediatric populations. ## Dose Adjustments * **Hepatic/Renal Impairment:** No specific adjustments defined; however, systemic absorption is negligible for intra-articular and ophthalmic routes. * **Geriatric:** No specific dose adjustments required; use caution in patients with history of joint infection or severe venous/lymphatic stasis in the target limb. ## Contraindications * Known hypersensitivity to hyaluronan-based products. * **Intra-articular:** Known hypersensitivity to avian (bird) proteins (for products derived from avian sources), history of infection in the target joint, or skin infections in the injection area. ## Adverse Effects * **Intra-articular:** Post-injection joint pain, stiffness, effusion, or transient swelling. Rare: pseudoseptic reaction (acute inflammatory response). * **Ophthalmic:** Transient increase in intraocular pressure, corneal edema. * **Dermal:** Bruising, erythema, swelling, nodules at injection site. Risk of serious tissue necrosis if accidentally injected into vasculature. ## Key Drug Interactions * **Quaternary Ammonium Salts:** Hyaluronic acid precipitates when mixed with quaternary ammonium salts (e.g., benzalkonium chloride); do not store or mix in containers containing these substances. * **Topical agents:** Avoid concomitant topical drugs at the administration site immediately following intradermal injection to prevent potential interference. ## Monitoring * **Intra-articular:** Monitor for signs of severe inflammation or joint infection (e.g., persistent heat, redness, systemic fever) post-injection. * **Ophthalmic:** Monitor intraocular pressure post-surgery. ## Clinical Pearls Products are not interchangeable; specific brands have unique molecular weights and cross-linking technologies. Always verify the manufacturer's package insert, as administration protocols (e.g., single-shot vs. multi-week series) vary significantly between identical-sounding indications. Ensure the joint is free of significant effusion before intra-articular injection. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice protocols and product-specific guidelines vary. Always consult the most current manufacturer prescribing information, institutional formulary, and clinical guidelines before prescribing or administering medication.